March 24, 2021
Article
If IVIG is commenced within 2 weeks from the onset of Guillain-Barre syndrome it can hasten recovery as much as plasma exchange, study indicates.
March 09, 2021
Researchers find no clear therapeutic benefit of intravenous immunoglobulin for the prevention of postnatal relapses of multiple sclerosis.
March 03, 2021
The first vaccine dose alone offered strong protection against COVID-19, with efficacy that did not decline over the 3 months between doses.
President Joseph Biden announced a partnership between Merck and Johnson & Johnson, in which 2 of Merck’s facilities will begin producing the Johnson & Johnson COVID-19 vaccine.
The availability of both intravenous and subcutaneous routes of immunoglobulin has made personalization of treatment more important than ever.
March 01, 2021
Investigators recommended avoiding risk factors such as smoking and switching to a transdermal administration route for testosterone.